The assessment of novel compounds for drug abuse potential provides critical information for the development of medications with maximized therapeutic benefit and minimized risk for abuse. These tests assess the abuse potential of novel compounds that exhibit specific effects (such as psychostimulant, depressant or hallucinogenic effects) on the central nervous system. The following tests are offered to assess the putative abuse liability of psychoactive drugs.